- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
产品描述 Decitabine is a DNA methyltransferase inhibitor that incorporates into DNA resulting in hypomethylation of DNA and intra-S-phase arrest of DNA replication. 靶点活性 DNA methyltransferase (DNMT), 体外活性 The IC50 values of Decitabine (5AZA) for both the HL-60 and KG1a leukemic cells for 72 and 96 h exposure were approximately 100 and 10 ng/ml, respectively. At drug concentrations of 1 ng/ml, KG1a cells were more sensitive to 5AZA than TSA or depsi; HL-60 cells were more sensitive to 5AZA than TSA and more sensitive to depsi than 5AZA [1]. Decitabine inhibited cell growth and induced G2/M arrest and apoptosis in EBVaGC cell lines. The expression of E-cadherin was up-regulated and cell motility was significantly inhibited in the cells treated with decitabine [2]. Exposure of HeLa cells to decitabine up-regulates the expression of several pyrimidine metabolic enzymes including DCTPP1, dUTPase, dCMP deaminase, and thymidylate synthase [3]. 体内活性 In initial experiments, mice were treated with 2.5 mg/kg/mouse of Decitabine (5-aza-CdR) by intraperitoneal injection every day. The time point of 5-aza-CdR administration after tumor injection significantly affected tumor growth. If 5-aza-CdR was administered for the first time 11 days after tumor inoculation when tumor size already exceeded 1 cm², and then for a period of eight days, a slight but not statistically significant decrease in tumor weight was detected compared to control mice [4]. At the 1 mg/kg dose tested, tetrahydrouridine (THU) increased Decitabine (DAC) plasma concentration (∼ 10-fold) as compared to DAC alone. Severe toxicity occurred in females receiving high-dose 1 mg/kg DAC + THU, requiring treatment discontinuation at week 5 [5]. Kinase Assay DNA synthesis assay : The rate of DNA synthesis is measured by the incorporation of radioactive thymidine into DNA. HL-60 and KG1a cells are suspended in 2 mL RPMI medium containing 10% fetal serum in 6-well (35 mm diameter) dishes and incubated with different concentrations of corresponding drugs for 48 hours (drugs are added simultaneously). At 48 hours, 0.5 μCi [3H] thymidine (6.7 Ci/mmol) is added to each well and incubated for an additional 24 hours. The cells are placed on GF/C glass fiber filters (2.4 cm diameter), washed with cold 0.9% NaCl, 5% cold trichloroacetic acid and ethanol. The filters containing the DNA are then dried, placed in EcoLite scintillation liquid (ICN) and the radioactivity measured using Beckman LS 6000IC scintillation counter. The IC50 is defined as the concentration of drug that inhibits 50% of the DNA synthesis of the leukemic cell lines from the dose–response curve. Cell Research For the growth inhibition assay, cells in log phase are placed in 5 mL of medium. Different concentrations of Decitabine are added to the medium simultaneously. Cell counts are performed at the indicated times using a model ZM Coulter Counter. The concentration that produces 50% inhibition of growth (IC50) is determined from the growth curves of the drug treated leukemic cell lines.(Only for Reference)
Cell lines: HL-60 and KG1a
Animal Research Animal Model: KARPAS-299 human cells are inoculated subcutaneously into the right and left flanks of the mice.
Animal Research Animal Model: BDF1 mice bearing lymphoid leukemia L1210
别名 5-Aza-2'-deoxycytidine, NSC 127716, Deoxycytidine, Dacogen 纯度 99.87% 分子量 228.21 分子式 C8H12N4O4 CAS No. 2353-33-5 参考文献:
5. Terse P, et al. Subchronic oral toxicity study of decitabine in combination with tetrahydrouridine in CD-1 mice. Int J Toxicol. 2014 Mar-Apr;33(2):75-85.6. Yu J, et al. DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. J Clin Invest. 2018 Jun 1;128(6):2376-2388.
关键词:- Decitabine
- 地西他滨
-
产品组分
组分内容
型号
规格 价格 储存温度
Decitabine【地西他滨】
T1508
5mg 0.00 -20°C Decitabine【地西他滨】 T1508
10mg 0.00 -20°C Decitabine【地西他滨】 T1508
25mg 0.00 -20°C Decitabine【地西他滨】 T1508
50mg 0.00 -20°C Decitabine【地西他滨】 T1508
100mg 0.00 -20°C Decitabine【地西他滨】 T1508
200mg 0.00 -20°C 操作手册 1 1